Literature DB >> 29887138

The cellular and pathologic prion protein.

Andrew C Gill1, Andrew R Castle2.   

Abstract

The cellular prion protein, PrPC, is a small, cell surface glycoprotein with a function that is currently somewhat ill defined. It is also the key molecule involved in the family of neurodegenerative disorders called transmissible spongiform encephalopathies, which are also known as prion diseases. The misfolding of PrPC to a conformationally altered isoform, designated PrPTSE, is the main molecular process involved in pathogenesis and appears to precede many other pathologic and clinical manifestations of disease, including neuronal loss, astrogliosis, and cognitive loss. PrPTSE is also believed to be the major component of the infectious "prion," the agent responsible for disease transmission, and preparations of this protein can cause prion disease when inoculated into a naïve host. Thus, understanding the biochemical and biophysical properties of both PrPC and PrPTSE, and ultimately the mechanisms of their interconversion, is critical if we are to understand prion disease biology. Although entire books could be devoted to research pertaining to the protein, herein we briefly review the state of knowledge of prion biochemistry, including consideration of prion protein structure, function, misfolding, and dysfunction.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  PRNP; amyloid; cofactors; conformational conversion; glycosylation; membrane anchor; misfolding; prion function; prion protein; toxicity

Mesh:

Substances:

Year:  2018        PMID: 29887138     DOI: 10.1016/B978-0-444-63945-5.00002-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  9 in total

1.  Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.

Authors:  Qi Shi; Cao Chen; Kang Xiao; Wei Zhou; Li-Ping Gao; Dong-Dong Chen; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  Neurosci Bull       Date:  2021-09-06       Impact factor: 5.203

Review 2.  Chronic Wasting Disease (CWD) in Cervids and the Consequences of a Mutable Protein Conformation.

Authors:  Christopher J Silva
Journal:  ACS Omega       Date:  2022-04-04

3.  Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep.

Authors:  Henrik Zetterberg; Elena Bozzetta; Alessandra Favole; Cristiano Corona; Maria Concetta Cavarretta; Francesco Ingravalle; Kaj Blennow; Maurizio Pocchiari; Daniela Meloni
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

Review 4.  Unzipping the Secrets of Amyloid Disassembly by the Human Disaggregase.

Authors:  Aitor Franco; Lorea Velasco-Carneros; Naiara Alvarez; Natalia Orozco; Fernando Moro; Adelina Prado; Arturo Muga
Journal:  Cells       Date:  2021-10-14       Impact factor: 6.600

Review 5.  Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.

Authors:  Firas Kobeissy; Abir Kobaisi; Wenjing Peng; Chloe Barsa; Mona Goli; Ahmad Sibahi; Samer El Hayek; Samar Abdelhady; Muhammad Ali Haidar; Mirna Sabra; Matej Orešič; Giancarlo Logroscino; Stefania Mondello; Ali H Eid; Yehia Mechref
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

6.  Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia.

Authors:  Hamish McManus; Clive R Seed; Veronica C Hoad; Philip Kiely; John M Kaldor; Claire E Styles; Hong Yang; Matthew Law; Iain B Gosbell
Journal:  Vox Sang       Date:  2022-05-24       Impact factor: 2.996

7.  Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.

Authors:  Anne Ward; Jason R Hollister; Kristin McNally; Diane L Ritchie; Gianluigi Zanusso; Suzette A Priola
Journal:  Acta Neuropathol Commun       Date:  2020-06-09       Impact factor: 7.801

8.  Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes.

Authors:  Helmut Hiller; Changjun Yang; Dawn E Beachy; Irina Kusmartseva; Eduardo Candelario-Jalil; Amanda L Posgai; Harry S Nick; Desmond Schatz; Mark A Atkinson; Clive H Wasserfall
Journal:  Diabetologia       Date:  2021-07-17       Impact factor: 10.122

9.  A Chinese patient with the clinical features of Parkinson's disease contains a single copy of octarepeat deletion in PRNP case report.

Authors:  Qi Shi; Xiao-Jing Shen; Li-Ping Gao; Kang Xiao; Wei Zhou; Yuan Wang; Cao Chen; Xiao-Ping Dong
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.